Genomics England Clinical Interpretation Partnerships announced

24 June 2015

Genomics England has announced details of a total of 31 different research domains to form the new Genomics England Clinical Interpretation Partnerships (GeCIPs).

The GeCIPs are intended to bring together multidisciplinary researchers and clinicians in order to speed the transfer of research findings arising from the 100,000 Genomes Project into clinical practice in the NHS.

Chief scientist Prof Mark Caulfield described the GeCIPs as “a powerful research and training programme alongside the 100,000 Genomes Project”, adding: “We want to ensure research findings go straight back to clinicians and patients so they can benefit and the GeCIP has been established to accelerate that”.  

The inaugural GeCIP meeting last week coincided with public release of the research domains. These span a range of different disease areas (including card iovascular and respiratory disease, paediatrics, neurological and musculoskeletal disease, endocrine and metabolic disorders) and a number of specific specialisms within oncology, as well as general cancer. These include familial (inherited) cancer predisposition, breast, colorectal, lung, ovarian and prostate cancers.

In addition, there are a number of cross-cutting GeCIP themes, notably population genomics, electronic records, validation and feedback, ethics and social science, health economics and education and training – not to mention the memorably named ‘Enabling Rare Disease Translational Genomics via Advanced Analytics and International Interoperability’ domain.

Earlier this month, Genomics England announced the names of four companies (selected from an earlier round of ten ‘finalists’) to provide clinical interpretation services. Subject to contractual agreement and other provisons, these will be Congenica and Omicia for rare diseases, Nanthealth for cancer, and Wuxi Nextcode for both rare diseases and cancer. 

The firms will provide automated services for the first 8-10,000 patients sequenced as part of the main phase of the 100,000 Genomes Project, working from within the new Genomics England data centre situated on the Genome Campus in Hinxton, near Cambridge, and starting from August 2015 with completion expected within a year.

Genomics England has also reportedly appointed data company Solid State Solutions (S3) to provide data storage for the 100,000 Genomes Project.

More from us

Genomics and policy news